{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:12:18Z","timestamp":1783944738223,"version":"3.55.0"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072958"],"award-info":[{"award-number":["P30AG072958"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retinal imaging offers a noninvasive window into neurodegenerative changes, yet its relationship with established cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) remains poorly understood. This study addresses a critical gap by examining whether retinal structural findings on optical coherence tomography (OCT) correlate with CSF biomarkers of AD pathology and neurodegeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine if CSF biomarkers correlate with retinal OCT imaging findings in individuals with AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, subjects underwent lumbar puncture for CSF collection and were imaged using the Zeiss Cirrus HD-5000 with AngioPlex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty participants (73 eyes) were included in this study. Twenty-one had normal cognition and negative CSF AD biomarkers, 12 had normal cognition and positive CSF AD biomarkers, and seven had mild cognitive impairment. Central subfield thickness (CST), retinal nerve fiber layer (RNFL), and ganglion cell inner plexiform layer (GCIPL) thicknesses were associated with CSF amyloid-\u03b2 42\/40 ratio (A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      ), phosphorylated tau at threonine 181 (pTau181)\/A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      ratio, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) using multivariable generalized estimating equations. There were no statistically significant associations between CSF pTau181\/A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      ratio, NfL, or GFAP and CST, GCIPL thickness, or RNFL thickness (p\u2009&gt;\u20090.05 for all). A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      ratio was positively associated with GCIPL thickness (p\u2009=\u20090.02), but not with CST or RNFL thickness (p\u2009=\u20090.31 and p\u2009=\u20090.82, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Decreased CSF A\u03b2\n                      <jats:sub>42\/40<\/jats:sub>\n                      ratio, a biomarker of amyloid plaque pathology, is associated with decreased GCIPL thickness. GCIPL thinning may correspond with CSF abnormalities consistent with amyloid pathology that is present even prior to cognitive decline.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877261423968","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:46:43Z","timestamp":1773254803000},"page":"1438-1446","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal fluid amyloid-\u03b2 42\/40 ratio is associated with ganglion cell-inner plexiform layer thinning in individuals with and without amyloid pathology"],"prefix":"10.1177","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-0492","authenticated-orcid":false,"given":"Hemal","family":"Patel","sequence":"first","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Choi","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Weng","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6612-0454","authenticated-orcid":false,"given":"Jamie","family":"Karl","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna","family":"Joseph","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-2489","authenticated-orcid":false,"given":"Kim G.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"},{"name":"Duke\/UNC Alzheimer's Disease Research Center, Durham, NC, USA"},{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Berger","sequence":"additional","affiliation":[{"name":"Duke\/UNC Alzheimer's Disease Research Center, Durham, NC, USA"},{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E.","family":"Whitson","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"},{"name":"Duke\/UNC Alzheimer's Disease Research Center, Durham, NC, USA"},{"name":"Duke University School of Medicine"},{"name":"Duke University School of Medicine"},{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilraj S.","family":"Grewal","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Fekrat","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"},{"name":"Eye Multimodal Imaging in Neurodegenerative Disease (iMIND) Study Group, Duke University School of Medicine, Durham, NC, USA"},{"name":"Duke\/UNC Alzheimer's Disease Research Center, Durham, NC, USA"},{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5847"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/543267"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature25456"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00168-5"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51676"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20191031-06"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20210528-06"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20180601-09"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.02.002"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255362"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-141659"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww015"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.3556"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56100553"},{"key":"e_1_3_3_19_2","article-title":"Macular ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimer's disease","volume":"11","author":"Choi SH","year":"2016","unstructured":"Choi SH, Park SJ, Kim NR. Macular ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimer's disease. PLoS One 2016; 11: e0162202.","journal-title":"PLoS One"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.wno.0000204645.56873.26"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3715-9"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.009"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00701"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000279"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09797-1"},{"key":"e_1_3_3_26_2","article-title":"Clinical application of CSF biomarkers for Alzheimer's disease: from rationale to ratios","volume":"14","author":"Bouwman FH","year":"2022","unstructured":"Bouwman FH, Frisoni GB, Johnson SC, et al. Clinical application of CSF biomarkers for Alzheimer's disease: from rationale to ratios. Alzheimers Dement (Amst) 2022; 14: e12314.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-00967-z"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009240"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0485-0"},{"key":"e_1_3_3_30_2","article-title":"P-tau\/Abeta42 and Abeta42\/40 ratios in CSF are equally predictive of amyloid PET status","volume":"13","author":"Campbell MR","year":"2021","unstructured":"Campbell MR, Ashrafzadeh-Kian S, Petersen RC, et al. P-tau\/Abeta42 and Abeta42\/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimers Dement (Amst) 2021; 13: e12190.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00665-8"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050753"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25152"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12131"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01249-0"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.200900048"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.05.018"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab223"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602841103"},{"key":"e_1_3_3_41_2","article-title":"Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia","volume":"14","author":"Thijssen EH","year":"2022","unstructured":"Thijssen EH, Verberk IMW, Kindermans J, et al. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Alzheimers Dement (Amst) 2022; 14: e12285.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.227"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/1759091414562107"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.06.020"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093165"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261423968","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261423968","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261423968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:44:02Z","timestamp":1783943042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261423968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/13872877261423968"],"URL":"https:\/\/doi.org\/10.1177\/13872877261423968","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}